Attached files
file | filename |
---|---|
10-K - Altimmune, Inc. | v178541_10k.htm |
EX-21 - Altimmune, Inc. | v178541_ex21.htm |
EX-31.2 - Altimmune, Inc. | v178541_ex31-2.htm |
EX-31.1 - Altimmune, Inc. | v178541_ex31-1.htm |
EX-32.2 - Altimmune, Inc. | v178541_ex32-2.htm |
EX-23.1 - Altimmune, Inc. | v178541_ex23-1.htm |
EX-10.30.1 - Altimmune, Inc. | v178541_ex10-30.htm |
EX-10.30.2 - Altimmune, Inc. | v178541_ex10-31.htm |
Exhibit 32.1
Certification
Pursuant to Section 1350 of Chapter 63
of
Title 18 of the United States Code
In
connection with the Annual Report of PharmAthene, Inc. (the “Company”) on
Form 10-K for the year ended December 31, 2009, as filed with the
Securities and Exchange Commission (the “Report”), I, David P. Wright, Chief
Executive Officer of the Company, certify, pursuant to 18 U.S.C.
Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley
Act of 2002, that to the best of my knowledge:
1.
|
The
Report fully complies with the requirements of Section 13(a) or
15(d) of the Securities Exchange
|
|
2.
|
The
information contained in the Report fairly presents, in all material
respects, the financial condition and results of operations of the
Company.
|
/s/
David P. Wright
|
|
David
P. Wright
|
|
Chief
Executive Officer
|
|
March
26, 2010
|